Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle

BACKGROUND: Cancer is considered the second leading cause of death in the world, and for the treatment of this disease, pharmacological intervention strategies are frequently based on chemotherapy. Doxorubicin (DOX) is one of the most widely used chemotherapeutic agents in clinical practice for trea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Cachexia Sarcopenia Muscle
Hauptverfasser: de Lima Junior, Edson Alves, Yamashita, Alex Shimura, Pimentel, Gustavo Duarte, De Sousa, Luís G. O., Santos, Ronaldo Vagner T, Gonçalves, Cinara Ludvig, Streck, Emilio Luiz, de Lira, Fábio Santos, Rosa Neto, Jose Cesar
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2016
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4863825/
https://ncbi.nlm.nih.gov/pubmed/27239415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12104
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge